Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: FDA employees do vital work that positively affects the health of each and every one of us…every day. Thank you to… https://t.co/RB6vTQExXg
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: FDA warns more companies to stop misleading kids with e-liquids that resemble kid-friendly foods as part of Youth T… https://t.co/UEmkUlQ4gq
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDATobacco: “Companies putting children at risk or enticing youth use are on notice. If you target kids, then we’re going to t… https://t.co/teEzm73iBX
SteveFDA (R-D.C.)
@SGottliebFDA
RT @AP_FDAwriter: California, Florida stem cell clinics target of US lawsuit (from @AP) https://t.co/saq96aqYda
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RareDiseases: Next week (5/17/18) during #NORD 35th Anniversary presenting the #RareImpact Awards, Dr. Richard Pazdur, Director o… https://t.co/mhnqKqSRl6
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: FDA seeks permanent injunctions against two stem cell clinics: https://t.co/IzRqcYu3Qc
SteveFDA (R-D.C.)
@SGottliebFDA
RT @NYTHealth: The FDA moves to stop Florida and California stem cell clinics from marketing therapies that are not approved. https://t.co/rNnomJbSOt
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SecAzar: Help is on the way for Americans facing high prescription drug prices. Read my @FoxNewsOpinion Op-Ed with @SeemaCMS… https://t.co/mLfJtkiQOD
SteveFDA (R-D.C.)
@SGottliebFDA
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA will take new actions next week as part of our ongoing campaign to address the youth use of e-cigarettes. We’ll target additional manufacturers next week who market electronic cigarettes that we believe may be more likely to be used by teens and kids
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSGov: #OutbreakUpdate: Check the egg carton in your home: 200+ million eggs have been recalled. Eggs produced by Rose Acr… https://t.co/vUoMJgtscj
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAJobs: Happy one year anniversary @SGottliebFDA !! https://t.co/GjSkwotDoK QT @SecAzar: One year ago today, @SGottliebFDA was sworn in as the 23rd Commissioner of Food & Drugs. Thank you for your bold le… https://t.co/8QcmvZZ8xp)
SteveFDA (R-D.C.)
@SGottliebFDA
Thank you @SecAzar for your support of me and, more importantly, the professional staff of #FDA and our mission to promote America’s public health https://t.co/btXa6tx0l9 QT @SecAzar: One year ago today, @SGottliebFDA was sworn in as the 23rd Commissioner of Food & Drugs. Thank you for your bold le… https://t.co/8QcmvZZ8xp)
SteveFDA (R-D.C.)
@SGottliebFDA
We appreciate the work with CHPA to address issues of abuse and misuse while also taking steps that protect patient access to needed medicine @scottmmelville https://t.co/UVp2qV2B0z QT @scottmmelville: CHPA and its member companies who manufacture OTC loperamide anti-diarrheal medicines are committed to working with… https://t.co/3UtrrnQiTo)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SecAzar: One year ago today, @SGottliebFDA was sworn in as the 23rd Commissioner of Food & Drugs. Thank you for your bold le… https://t.co/8QcmvZZ8xp
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSMedia: "@POTUS made history today, by laying out the most comprehensive plan of action for prescription drug affordability… https://t.co/X5zCD46u6D
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: Statement from @SGottliebFDA on the Trump Administration’s plan to lower drug prices: https://t.co/zEsyt4jq2S
SteveFDA (R-D.C.)
@SGottliebFDA
Thank you much @califf001 for your words of support and your continued counsel https://t.co/I6h86CePXr QT @califf001: A job well done at FDA. Congrats. https://t.co/sjaFf3QkeX)
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA will continue the momentum of our Drug Competition Action Plan and announce more new steps in the coming weeks to encourage generic and biosimilar development, lower costs for patients, improved access https://t.co/3ukC7rrdTi https://t.co/RBlMkbjhEJ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @WhiteHouse: .@US_FDA's 2017 generic drug approvals contributed to prescription drug buyers saving $8.8 billion. These dramatic… https://t.co/KjqmngTjHI